Dr. Bakhos Tannous is an internationally renowned scientist, educator and administrative leader. Dr. Tannous has created a legacy of multidisciplinary team to tackle some of the most pressing challenges in cancer in general and brain tumors in particular, including new views for diagnosis and therapy. Dr. Tannous is a Professor of Neurology at Harvard Medical School and serves as the Director for the Experimental Therapeutics Unit, Co-Director of the Molecular Neurogenetics Unit-East, Director of the MGH Viral Vector Development Core, and Director of the Postdoctoral Division at the Massachusetts General Hospital. His research interest includes high-throughput drug discovery, developing of novel proteolysis targeting chimera (PROTAC) for targeted protein degradation, as well as gene/cell therapies, with a primary focus on pediatric and adult malignant brain tumors as well as brain metastasis. Dr. Tannous received many prestigious awards such as the Young Investigator Award from the Society for Molecular Imaging for 3 years in a row, National Cancer Institute Howard Temin Pathway to Independence Award in cancer research, Outstanding Investigator Award from the American Society for Gene and Cell Therapy, Massachusetts General Hospital Partners in Excellence Award, Beirut Golden Award for outstanding achievement, and several Outstanding Mentor Award. He is a member of organizing committee of many national and international meetings including the American Society for Gene and Cell Therapy, Society for Neuro-Oncology, and European Society for Medical Oncology.